◆英語タイトル:The Jackson Laboratory - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013204
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
The Jackson Laboratory (JAX) is a nonprofit biomedical research institution that offers genomic solutions. The institution offers services in the therapeutic areas of cardiovascular, metabolic diseases, oncology, rare diseases, and neurobiology. It offers breeding and rederivation services, which include breeding services, speed expansion, rederivation, speed congenic development and strain rescue. JAX provides cryopreservation and recovery services such as sperm cryopreservation, on-site sperm cryopreservation, embryo cryopreservation, cryo storage, cryorecovery and sponsored strain distribution. It provides various surgical procedures including hysterectomy, ovariectomy, vasectomy, jejunum catheterization, microchip insertion, brain cannulation, cholecystectomy, and others. The institution offers in vivo pharmacology services, such as in vivo services, oncology, inflammatory and autoimmune disease, neuromuscular and neurodegenerative disorders, and in vivo pharmacology services facility. JAX is headquartered in Bar Harbor, Maine, the US.
The Jackson Laboratory – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Jackson Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The Jackson Laboratory, Medical Devices Deals, 2011 to YTD 2017 9
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Crown Bioscience and Jackson Lab Enter into Agreement 11
Jackson Labs and University of Connecticut Form Joint Venture 12
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 13
CollabRx Enters Into Agreement With Jackson Labs 14
Jackson Labs Enters Into Research Agreement With Hartford Hospital And Connecticut Children’s Medical Care For Cancer Treatment 15
Licensing Agreements 17
Jackson Laboratory Enters into Licensing Agreement with Caribou Biosciences 17
Cyteir Therapeutics Enters into Licensing Agreement with Jackson Laboratory 18
The Jackson Laboratory – Key Competitors 19
The Jackson Laboratory – Key Employees 20
The Jackson Laboratory – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 23
Sep 27, 2017: NIH Awards $10.6M Research Center Grant To The Jackson Laboratory For Study Of Chronic Fatigue Syndrome 24
Sep 18, 2017: New $5.4M grant funds JAX studies of ‘cognitive resilience’ to Alzheimer’s disease 25
Sep 10, 2017: $2.1M National Eye Institute grant funds JAX research in inherited retinal diseases 26
Aug 20, 2017: Jax Receives $2M Federal Grant to Study Role of RNA Structure In Gene Regulation 27
Aug 15, 2017: New $1.9M federal grant to fund JAX studies of microbiome’s role in multiple sclerosis 28
Aug 14, 2017: $2.3M in federal funding to JAX to support studies of aging immune system 29
May 14, 2017: New $2.7M Federal Grant Awarded To Jax Alzheimer’s Researcher 30
May 14, 2017: New $3.2M federal grant awarded to JAX Alzheimers researcher 31
Mar 02, 2017: $2.8 million in federal grants to JAX scientists to target triple-negative breast cancers 32
Mar 01, 2017: JAX receives NIH grant to improve CRISPR-Cas9 accuracy 34
Mar 01, 2017: JAX Receives Federal Grant To Improve CRISPR-Cas9 Accuracy, Efficiency And Reliability 35
Feb 03, 2017: JAX receives $6.7 million federal research grant to create 3-D genome map 36
Aug 08, 2016: NIH Grant To Fund New Center For Systems Neurogenetics Of Addiction 37
Product News 38
Feb 08, 2016: JAX Expands Availability Of NSG-SGM3 Mouse Model To Fast-Track Disease Cures 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
The Jackson Laboratory, Pharmaceuticals & Healthcare, Key Facts 2
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Jackson Laboratory, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Jackson Laboratory, Deals By Therapy Area, 2011 to YTD 2017 8
The Jackson Laboratory, Medical Devices Deals, 2011 to YTD 2017 9
The Jackson Laboratory, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Crown Bioscience and Jackson Lab Enter into Agreement 11
Jackson Labs and University of Connecticut Form Joint Venture 12
Jackson Lab Enters into Co-Development Agreement with Beth Israel Deaconess Medical Center 13
CollabRx Enters Into Agreement With Jackson Labs 14
Jackson Labs Enters Into Research Agreement With Hartford Hospital And Connecticut Children's Medical Care For Cancer Treatment 15
Jackson Laboratory Enters into Licensing Agreement with Caribou Biosciences 17
Cyteir Therapeutics Enters into Licensing Agreement with Jackson Laboratory 18
The Jackson Laboratory, Key Competitors 19
The Jackson Laboratory, Key Employees 20
The Jackson Laboratory, Other Locations 22